Citations (91)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Anselm Wong, Robert S. Hoffman, Steven J. Walsh, Darren M. Roberts, Sophie Gosselin, Timothy E. Bunchman, Sofia Kebede, Valery Lavergne & Marc Ghannoum. (2021) Extracorporeal treatment for calcium channel blocker poisoning: systematic review and recommendations from the EXTRIP workgroup. Clinical Toxicology 59:5, pages 361-375.
Read now
Read now
Amol A. Raje, Radni D. Deshpande, Vishal V. Pathade, Vallabh Mahajan, Kaushal Joshi, Ashwini Tambe, Ramana Jinugu, Vamsi L. M. Madgula, Ashwani Gaur, Vishwottam Kandikere, Chandragouda R. Patil & Kasim A. Mookhtiar. (2018) Evaluation of separate role of intestine and liver in first pass metabolism of budesonide in rat. Xenobiotica 48:12, pages 1206-1214.
Read now
Read now
Hideyoshi Matsumura, Kenjiro Takagi, Hiroyuki Seki, Yoshihisa Ono, Shunichiro Ichinose, Hiroko Masuko, Mayumi Fukatsu, Aiji Miyashita & Ayako Mera. (2014) Placental transfer of intravenous nicardipine and disposition into breast milk during the control of hypertension in women with pre-eclampsia. Hypertension in Pregnancy 33:1, pages 93-101.
Read now
Read now
Tjerk Bueters, Sanja Juric, Anna-Karin Sohlenius-Sternbeck, Yin Hu & Johan Bylund. (2013) Rat poorly predicts the combined non-absorbed and presystemically metabolized fractions in the human. Xenobiotica 43:7, pages 607-616.
Read now
Read now
Yeamin Huh, David E Smith & Meihau Rose Feng. (2011) Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs. Xenobiotica 41:11, pages 972-987.
Read now
Read now
Solomon Aronson. (2009) Clevidipine in the treatment of perioperative hypertension: assessing safety events in the ECLIPSE trials. Expert Review of Cardiovascular Therapy 7:5, pages 465-472.
Read now
Read now
T. TERAMURA*T. WATANABE, S. HIGUCHI & K. HASHIMOTO. (1997) Metabolism and pharmacokinetics of barnidipine hydrochloride, a calcium channel blocker, in man following oral administration of its sustained release formulation. Xenobiotica 27:2, pages 203-216.
Read now
Read now
T. Teramura, T. Watanabe, S. Higuchi & K. Hashimoto. (1995) Pharmacokinetics of barnidipine hydrochloride, a new dihydropyridine calcium channel blocker, in the rat, dog and human. Xenobiotica 25:11, pages 1237-1246.
Read now
Read now
Dennis A. Smith. (1991) Species Differences in Metabolism and Pharmacokinetics: Are We Close to an Understanding?. Drug Metabolism Reviews 23:3-4, pages 355-373.
Read now
Read now
M. Pellegatti, P. Grossi, J. Ayrton, G. L. Evans & A. J. Harker. (1990) Absorption, distribution and excretion of lacidipine, a dihydropyridine calcium antagonist, in rat and dog. Xenobiotica 20:8, pages 765-777.
Read now
Read now
Y. Tokuma, M. Sekiguchi, T. Niwa & H. Noguchi. (1988) Pharmacokinetics of nilvadipine, a new dihydropyridine calcium antagonist, in mice, rats, rabbits and dogs. Xenobiotica 18:1, pages 21-28.
Read now
Read now
Y. Tokuma, T. Fujiwara & H. Noguchi. (1987) Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs. Xenobiotica 17:11, pages 1341-1349.
Read now
Read now
W. R. Rush, O. Alexander, D. J. Hall, L. Cairncross, R. J. Dow & D. J. G. Graham. (1986) The metabolism of nicardipine hydrochloride in healthy male volunteers. Xenobiotica 16:4, pages 341-349.
Read now
Read now
Bruce Clark, Dennis A. Smith & John Caldwell. (1984) Pharmacokinetics and Toxicity Testing. CRC Critical Reviews in Toxicology 12:4, pages 343-385.
Read now
Read now
C. Bäärnhielm, I. Skånberg & K. O. Borg. (1984) Cytochrome P-450-dependent oxidation of felodipine—a 1,4-dihydropyridine—to the corresponding pyridine. Xenobiotica 14:9, pages 719-726.
Read now
Read now
S. Higuchi, H. Sasaki & T. Seki. (1980) Pharmacokinetic studies on nicardipine hydrochloride, a new vasodilator, after repeated administration to rats, dogs and humans. Xenobiotica 10:12, pages 897-903.
Read now
Read now
S. Higuchi & Y. Shiobara. (1980) Metabolic fate of nicardipine hydrochloride, a new vasodilator, by various species in vitro. Xenobiotica 10:12, pages 889-896.
Read now
Read now
Articles from other publishers (74)
Young‐Heun Jung, Dong‐Gyu Heo, Dong‐Cheol Lee, Ye‐Min Kwon, Mi‐Ji Seol, Didi Zhang, Tae Cheon Jeong & Ju‐Hyun Kim. (2022) Effect of concomitant oral administration of ethanol on the pharmacokinetics of nicardipine in rats. Biomedical Chromatography 36:9.
Crossref
Crossref
Christopher R. Jones, Oliver J. D. Hatley, Anna-Lena Ungell, Constanze Hilgendorf, Sheila Annie Peters & Amin Rostami-Hodjegan. (2016) Gut Wall Metabolism. Application of Pre-Clinical Models for the Prediction of Human Drug Absorption and First-Pass Elimination. The AAPS Journal 18:3, pages 589-604.
Crossref
Crossref
Sang-Bae Ko, H. Alex Choi, Raimund Helbok, Pedro Kurtz, J. Michael Schmidt, Neeraj Badjatia, Jan Claassen, E. Sander Connolly, Stephan A. Mayer & Kiwon Lee. (2016) Acute effects of intraventricular nicardipine on cerebral hemodynamics: A preliminary finding. Clinical Neurology and Neurosurgery 144, pages 48-52.
Crossref
Crossref
Shinji Yamashita, Makoto Kataoka, Yuki Suzaki, Hiromitsu Imai, Takuya Morimoto, Kyoichi Ohashi, Akihiro Inano, Kazutaka Togashi, Kuninori Mutaguchi & Yuichi Sugiyama. (2015) An Assessment of the Oral Bioavailability of Three Ca-Channel Blockers Using a Cassette-Microdose Study: A New Strategy for Streamlining Oral Drug Development. Journal of Pharmaceutical Sciences 104:9, pages 3154-3161.
Crossref
Crossref
Can Ozan Tan, J. W. Hamner & J. Andrew Taylor. (2013) The role of myogenic mechanisms in human cerebrovascular regulation. The Journal of Physiology 591:20, pages 5095-5105.
Crossref
Crossref
Milan Bruncko. 2012. Bioactive Heterocyclic Compound Classes. Bioactive Heterocyclic Compound Classes
135
151
.
Junko Mizumura, Nobutoshi Watari & Shigesada Higuchi. (1998) Possibility of Partial Absorption of Nicardipine by Routes Other Than the Hepato-portal System After Oral Administration in Rats. Journal of Pharmacy and Pharmacology 50:7, pages 775-781.
Crossref
Crossref
Nobuyuki Sugioka, Hikaru Koyama, Mariko Kawakubo, Toshio Ohta, Hideki Kishimoto, Satoru Mori & Kenji Nakajima. (1996) Age-dependent Alteration of the Serum-unbound Fraction of Nicardipine, a Calcium-channel Blocker, in Man. Journal of Pharmacy and Pharmacology 48:12, pages 1327-1331.
Crossref
Crossref
Evelyn Moreno-Calvo, María Muntó, Klaus Wurst, Nora Ventosa, Norberto Masciocchi & Jaume Veciana. (2011) Polymorphs and Solvates of Nicardipine Hydrochloride. Selective Stabilization of Different Diastereomeric Racemates. Molecular Pharmaceutics 8:2, pages 395-404.
Crossref
Crossref
Keitaro Kadono, Takafumi Akabane, Kenji Tabata, Katsuhiko Gato, Shigeyuki Terashita & Toshio Teramura. (2010) Quantitative Prediction of Intestinal Metabolism in Humans from a Simplified Intestinal Availability Model and Empirical Scaling Factor. Drug Metabolism and Disposition 38:7, pages 1230-1237.
Crossref
Crossref
Jun-Shik Choi, Young-Youp Koh, Joong-Hwa Chung, Dong-Hyun Choi & Hyo-Kyung Han. (2008) Reduced prehepatic extraction of nicardipine in the presence of pioglitazone in rats. Journal of Pharmacy and Pharmacology 60:10, pages 1403-1407.
Crossref
Crossref
Iftekhar Mahmood. (2009) Role of Fixed Coefficients and Exponents in the Prediction of Human Drug Clearance: How Accurate are the Predictions from One or Two Species?. Journal of Pharmaceutical Sciences 98:7, pages 2472-2493.
Crossref
Crossref
Naoe Yamane, Tomonori Takami, Zenzaburo Tozuka, Yuichi Sugiyama, Akira Yamazaki & Yuji Kumagai. (2009) Microdose Clinical Trial: Quantitative Determination of Nicardipine and Prediction of Metabolites in Human Plasma. Drug Metabolism and Pharmacokinetics 24:4, pages 389-403.
Crossref
Crossref
Kosalaram Goteti, Patrick J. Brassil, Steven S. Good & C. Edwin Garner. (2008) Estimation of Human Drug Clearance Using Multiexponential Techniques. The Journal of Clinical Pharmacology 48:10, pages 1226-1236.
Crossref
Crossref
Joseph Varon. (2008) Treatment of Acute Severe Hypertension. Drugs 68:3, pages 283-297.
Crossref
Crossref
Motohiro Kato. (2008) Intestinal First-Pass Metabolism of CYP3A4 Substrates. Drug Metabolism and Pharmacokinetics 23:2, pages 87-94.
Crossref
Crossref
Shoji MIYAJIMA, Kiyomitsu NEMOTO, Masashi SEKIMOTO, Yusuke KINAE, Toshihiko KASAHARA, Shinji SOUMA & Masakuni DEGAWA. (2007) INDUCTION OF HEPATIC CYTOCHROME P450 ISOFORMS BY NICARDIPINE AT THERAPEUTIC DOSES IN SPONTANEOUSLY HYPERTENSIVE RATS. The Journal of Toxicological Sciences 32:1, pages 79-90.
Crossref
Crossref
Nobuyuki Tanaka, Keiji Imai, Kazuto Okimoto, Satoshi Ueda, Yuji Tokunaga, Rinta Ibuki, Kazutaka Higaki & Toshikiro Kimura. (2006) Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): In vivo evaluation. Journal of Controlled Release 112:1, pages 51-56.
Crossref
Crossref
Takeru Kohinata, Mitsuo FujiiSouichiro NakamuraNoritaka HamadaEtsuo Yonemochi & Katsuhide Terada. (2004) Quantitative Determination of Amorphous Nicardipine Hydrochloride in Long Acting Formula (NIC-LA) Using Light Anhydrous Silicic Acid. Chemical and Pharmaceutical Bulletin 52:12, pages 1451-1457.
Crossref
Crossref
Toshihiro Wajima, Kazuya Fukumura, Yoshitaka Yano & Takayoshi Oguma. (2003) Prediction of Human Pharmacokinetics from Animal Data and Molecular Structural Parameters using Multivariate Regression Analysis: Oral Clearance. Journal of Pharmaceutical Sciences 92:12, pages 2427-2440.
Crossref
Crossref
Motohiro Kato, Koji Chiba, Akihiro Hisaka, Michi Ishigami, Makoto Kayama, Naomi Mizuno, Yoshinori Nagata, Susumu Takakuwa, Yuko Tsukamoto, Kaoru Ueda, Hiroyuki Kusuhara, Kiyomi Ito & Yuichi Sugiyama. (2003) The Intestinal First-pass Metabolism of Substrates of CYP3A4 and P-glycoprotei—Quantitative Analysis Based on Information from the Literature. Drug Metabolism and Pharmacokinetics 18:6, pages 365-372.
Crossref
Crossref
Catarina Marques Fernandes & Francisco José Baptista Veiga. (2003) A simple method for nicardipine hydrochloride quantification in plasma using solid‐phase extraction and reversed‐phase high‐performance liquid chromatography. Biomedical Chromatography 17:1, pages 33-38.
Crossref
Crossref
Hiroshi Ikegaya, Masahiko Kobayashi, Koichi Sakurada, Hisako Takeichi, Ken-ichi Yoshida & Hirotaro Iwase. (2002) Detection of the calcium antagonist nicardipine and its metabolites by gas chromatography–mass spectrometry. Forensic Science International 130:1, pages 25-28.
Crossref
Crossref
Teh-Min Hu & William L. Hayton. (2015) Allometric scaling of xenobiotic clearance: Uncertainty versus universality. AAPS PharmSci 3:4, pages 30-43.
Crossref
Crossref
Michael B. Murphy, Clare Murray & George D. Shorten. (2001) Fenoldopam — A Selective Peripheral Dopamine-Receptor Agonist for the Treatment of Severe Hypertension. New England Journal of Medicine 345:21, pages 1548-1557.
Crossref
Crossref
Waranush Sorasuchart & James W. Ayres. (2001) Preliminary bioequivalence testing of two nicardipine HCl sustained-release formulations with in vitro/in vivo correlations. European Journal of Drug Metabolism and Pharmacokinetics 26:1-2, pages 1-7.
Crossref
Crossref
Masamitsu Fukuzawa, Jo Satoh, Setsu Ohta, Kazuma Takahashi, Shuichi Miyaguchi, Xiaoling Qiang, Yoshiyuki Sakata, Tetsuya Nakazawa, Yumiko Takizawa & Takayoshi Toyota. (2000) Modulation of tumor necrosis factor-α production with anti-hypertensive drugs. Immunopharmacology 48:1, pages 65-74.
Crossref
Crossref
A. Mrhar, M. Bogataj, I. Grabnar & R. Karba. (1999) Formulation of controlled release microspheres containing nicardipine: the role of pharmacokinetic modeling and computer simulation. European Journal of Drug Metabolism and Pharmacokinetics 24:1, pages 55-61.
Crossref
Crossref
Ke Li, Xin Zhang, Yi-sheng Yuan & Fei-lang Zhao. (1998) A high-performance liquid chromatographic method for the determination of nicardipine in plasma and its application to pharmacokinetics in humans. Biomedical Chromatography 12:6, pages 326-329.
Crossref
Crossref
Toshiharu Sakai, Toshio Teramura, Hideaki Okamiya & Osamu Inagaki. (2007) A Review on Barnidipine: A Novel Calcium Antagonist. Cardiovascular Drug Reviews 15:4, pages 273-290.
Crossref
Crossref
Tsukasa Uno, Tadashi Ohkubo & Kazunobu Sugawara. (1997) Enantioselective high-performance liquid chromatographic determination of nicardipine in human plasma. Journal of Chromatography B: Biomedical Sciences and Applications 698:1-2, pages 181-186.
Crossref
Crossref
Shizuo Yamada & Ryohei Kimura. (2007) Pharmacodynamics and Pharmacokinetics of Iganidipine. Cardiovascular Drug Reviews 14:3, pages 213-230.
Crossref
Crossref
Keiji Nishida & S.P Markey. (1996) Nicardipine and MK-801 attenuate platelet-activating factor increases following cerebral ischemia-reperfusion in gerbils. Brain Research 733:2, pages 203-210.
Crossref
Crossref
Hideyuki Nomura, Chika Morita, Shinichiro Kuwano, Hiroshi Eto, Hiroshi Goto & Hiroshi Kuwahara. (1996) Efficacy of combination antiplatelet therapy and nicardipine for chronic cerebral infarction. Clinical Therapeutics 18:3, pages 483-490.
Crossref
Crossref
K BachmannD PardoeD White. (1996) Scaling basic toxicokinetic parameters from rat to man.. Environmental Health Perspectives 104:4, pages 400-407.
Crossref
Crossref
Minoru Yamamoto & Tohichi Takenaka. (2006) Neuroprotective Action of Nicardipine Hydrochloride. CNS Drug Reviews 1:1, pages 91-106.
Crossref
Crossref
Yutaka Inoue, Hironobu Nakamura, Hideyo Akaji & Kolchi Yamasaki. (1995) Indirect portography enhanced by nicardipine versus prostaglandin E1. Cardiovascular and Interventional Radiology 18:2, pages 92-96.
Crossref
Crossref
S. Uchida, S. Yamada, T. Ohkura, M. Heshikiri, A. Yoshimi, H. Shirahase & R. Kimura. (2012) The receptor occupation and plasma concentration of NKY‐722, a water‐soluble dihydropyridine‐type calcium antagonist, in spontaneously hypertensive rats. British Journal of Pharmacology 114:1, pages 217-223.
Crossref
Crossref
Per Sjöberg. (2016) Toxicokinetics in Preclinical Safety Assessment—Views of the Swedish Medical Products Agency. Drug Information Journal 28:1, pages 151-157.
Crossref
Crossref
Roger Burges & Donna Moisey. (1994) Unique pharmacologic properties of amlodipine. The American Journal of Cardiology 73:3, pages A2-A9.
Crossref
Crossref
Harold E. Bays, Carlos Dujovne, Eric J. Lien, Hua Gao, Linda L. Lien, N. Seiler, C. L. Atanassov, Shradha Sinha, Mukta Srivastava, Mark P. Hayes & Kathryn C. ZoonEric J. Lien, Hua Gao & Linda L. Lien. 1994. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques
43
86
.
Nishit B. Modi, Veng-Pedersen Peter, Doug J. Graham & Rob J. Dow. (1993) Application of a System Analysis Approach to Population Pharmacokinetics and Pharmacodynamics of Nicardipine Hydrochloride in Healthy Males. Journal of Pharmaceutical Sciences 82:7, pages 705-713.
Crossref
Crossref
K KumagaiH SuzukiM RyuzakiH KumagaiM IchikawaM JimboY MatsumuraT Saruta. (1992) Effects of antihypertensive agents on arterial baroreceptor reflexes in conscious rats.. Hypertension 20:5, pages 701-709.
Crossref
Crossref
Shoji Takakura, Keizo Sogabe, Hisashi Satoh, Jo Mori, Tomoichi Fujiwara, Zenzaburou Totsuka, Yoji Tokuma & Masanobu Kohsaka. (1992) Nilvadipine as a neuroprotective calcium entry blocker in a rat model of global cerebral ischemia. A comparative study with nicardipine hydrochloride. Neuroscience Letters 141:2, pages 199-202.
Crossref
Crossref
Koichi Kawai, Seiji Suzuki, Yasuko Murayama, Yasuko Watanabe & Kamejiro Yamashita. (1992) Comparison of the effects of nilvadipine and captopril on glucose and lipid metabolism in NIDDM patients with hypertension. Diabetes Research and Clinical Practice 16:2, pages 137-143.
Crossref
Crossref
B Le GrandS HatemE DeroubaixJ P CouetilE Coraboeuf. (1991) Calcium current depression in isolated human atrial myocytes after cessation of chronic treatment with calcium antagonists.. Circulation Research 69:2, pages 292-300.
Crossref
Crossref
Natsuki Nakayama, Katsumi Ikezono, Naoki Fujio, Hiroyuki Sasabe, Keisuke Kitaura, Shigeharu Tamada, Toshinobu Shirafuji & Youichi Yabuuchi. (2007) OPC‐13340, a New Potent and Long‐Acting Dihydropyridine Calcium Antagonist. Cardiovascular Drug Reviews 9:2, pages 147-157.
Crossref
Crossref
J. P. Castel. 1991. Advances and Technical Standards in Neurosurgery. Advances and Technical Standards in Neurosurgery
47
110
.
Harold P. AdamsJrJr. (2021) Calcium Antagonists in the Management of Patients with Aneurysmal Subarachnoid Hemorrhage: A Review. Angiology 41:11, pages 1010-1016.
Crossref
Crossref
Bramah N. Singh & Martin A. Josephson. (1990) Clinical pharmacology, pharmacokinetics, and hemodynamic effects of nicardipine. American Heart Journal 119:2, pages 427-434.
Crossref
Crossref
Kenji Morishima, Ritsuko Tahara & Masato Horiuchi. (1990) Determination of a new calcium antagonist, sesamodil fumarate (SD-3211), and its metabolite in plasma by liquid chromatography with electrochemical detection. Journal of Chromatography B: Biomedical Sciences and Applications 527, pages 381-388.
Crossref
Crossref
S. Kazda & A. Knorr. 1990. Pharmacology of Antihypertensive Therapeutics. Pharmacology of Antihypertensive Therapeutics
301
375
.
Christian Begon, Bruno Dartayet, Alain Edouard, Didier David & Kamran Samii. (1989) Intravenous nicardipine for treatment of intraoperative hypertension during abdominal surgery. Journal of Cardiothoracic Anesthesia 3:6, pages 707-711.
Crossref
Crossref
T. Tsukahara, A. Arista & N.F. Kassell. (1989) The distribution of intravenous nicardipine in rat brain after subarachnoid hemorrhage. Surgical Neurology 32:3, pages 188-194.
Crossref
Crossref
M. Guerret, G. Cheymol, M. Hubert, C. Julien-Larose & D. Lavene. (1989) Simultaneous study of the pharmacokinetics of intravenous and oral nicardipine using a stable isotope. European Journal of Clinical Pharmacology 37:4, pages 381-385.
Crossref
Crossref
G. Baillet, A. Pourcelot, A. Weil, C. Prevost & P. Guichard. (1988) Radio high-performance liquid chromathographic determination of 14C-labelled LF 2-0254, A 1,4-dihydropyridine calcium antagonist, in rat and dog plasma using off-line liquid scintillation counting. Journal of Chromatography A 456, pages 183-190.
Crossref
Crossref
P.O. Greiner, D. Angignard & J. Cahn. (1988) High Performance Liquid Chromatography of a New 1,4-Dihydropyridine: Applications to Pharmacokinetic Study in Dogs. Journal of Pharmaceutical Sciences 77:5, pages 387-389.
Crossref
Crossref
Eugene S. Flamm, Harold P. AdamsJr.Jr., David W. Beck, Richard S. Pinto, John R. Marler, Michael D. Walker, John C. Godersky, Christopher M. Loftus, José Biller, David J. Boarini, Chris O'Dell, Karla Banwart & Gail Kongable. (1988) Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 68:3, pages 393-400.
Crossref
Crossref
Masato Terakawa, Yoji Tokuma, Akira Shishido, Kohtaro Yasuda & Hideyo Noguchi. (2013) Effect of Two Different Meals on Bioavailability of Nilvadipine in Healthy Volunteers. The Journal of Clinical Pharmacology 27:4, pages 293-296.
Crossref
Crossref
John G. Wagner, Teck L. Ling, Edward J. Mroszczak, Donna Freedman, Ann Wu, Bee Huang, Ian J. Massey & Robert R. Roe. (1987) Single intravenous dose and steady-state oral dose pharmacokinetics of nicardipine in healthy subjects. Biopharmaceutics & Drug Disposition 8:2, pages 133-148.
Crossref
Crossref
Anne T. Wu, Ian J. Massey & Stanley Kushinsky. (1987) Capillary column gas chromatographic method using electron-capture detection for the simultaneous determination of nicardipine and its pyridine metabolite II in plasma. Journal of Chromatography B: Biomedical Sciences and Applications 415, pages 65-73.
Crossref
Crossref
Shin-Ichiro Kobayashi. (1987) Simple method for the determination of nicardipine in plasma using high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications 420, pages 439-444.
Crossref
Crossref
R. J. DOW & D. J. M. GRAHAM. (1986) A review of the human metabolism and pharmacokinetics of nicardipine hydrochloride. British Journal of Clinical Pharmacology 22, pages 195S-202S.
Crossref
Crossref
Mohamed A. A. Saad, Jean‐Luc Elghozi & Philippe Meyer. (2007) BAROREFLEX SENSITIVITY ALTERATION FOLLOWING TRANSIENT HEMISPHERIC ISCHAEMIA IN RATS: PROTECTIVE EFFECT OF ALPHAMETHYLDOPA AND GUANFACINE. Clinical and Experimental Pharmacology and Physiology 13:7, pages 525-534.
Crossref
Crossref
J Grotta, J Spydell, C Pettigrew, P Ostrow & D Hunter. (1986) The effect of nicardipine on neuronal function following ischemia.. Stroke 17:2, pages 213-219.
Crossref
Crossref
G.C. Visor, E. Bajka & E. Benjamin. (1986) Intranasal Delivery of Nicardipine in the Rat. Journal of Pharmaceutical Sciences 75:1, pages 44-46.
Crossref
Crossref
Scott R. Hamann, Michael T. Piascik & R. G. McAllisterJr.Jr.. (2006) Aspects of the clinical pharmacology of nifedipine, a dihydropyridine calcium‐entry antagonist. Biopharmaceutics & Drug Disposition 7:1, pages 1-10.
Crossref
Crossref
Masayasu Hamaji, Masahiko Miyata, Ryuzo Kawamori, Motoaki Shichiri, Takashi Mashimo, Kazuyasu Nakao & Yasunaru Kawashima. (1985) Blood glucose control by an artificial endocrine pancreas in a patient with phaeochromocytoma. Canadian Anaesthetists’ Society Journal 32:5, pages 538-542.
Crossref
Crossref
Satoshi Takeo, Kyoko Adachi & Matao Sakanashi. (1985) A possible action of nicardipine on the cardiac sarcolemmal Na+-Ca2+ exchange. Biochemical Pharmacology 34:13, pages 2303-2308.
Crossref
Crossref
Sherrin H. Baky. (2007) Nicardipine Hydrochloride. Cardiovascular Drug Reviews 3:1, pages 153-172.
Crossref
Crossref
DJ Graham, RJ Dow, DJ Hall, OF Alexander, EJ Mroszczak & D. Freedman. (2012) The metabolism and pharmacokinetics of nicardipine hydrochloride in man.. British Journal of Clinical Pharmacology 20:S1.
Crossref
Crossref
Volker Hossmann, Jürgen Grötz & Karsten SchrörK. Schrör. 1985. Kalziumantagonisten und zerebrale Erkrankungen. Kalziumantagonisten und zerebrale Erkrankungen
1
39
.
Anne T. Wux, Ian J. Massey & Stanley Kushinsky. (1984) A High-Performance Liquid Chromatographic Method for The Simultaneous Determination of Nicardipine and Its Pyridine Metabolite II in Plasma. Journal of Pharmaceutical Sciences 73:10, pages 1444-1447.
Crossref
Crossref
S. Higuchi & S. Kawamura. (1981) Specific determination of plasma nicardipine hydrochloride levels by gas chromatography—mass spectrometry. Journal of Chromatography B: Biomedical Sciences and Applications 223:2, pages 341-349.
Crossref
Crossref